Divi's Labs Q3 net profit zooms 66% to Rs 594 crore
Divi's Laboratories on Monday reported a 66% year-on-year (YoY) jump in net profit to Rs 594 crore for the quarter ended December 31, 2024 led by growth in custom synthesis and stable generics business.
The company reported net profit of Rs 358 crore in the corresponding quarter of the previous year.
Revenue rose 25% YoY to Rs 2379 crore in Q3FY25.
The company generates about 53% of sales from custom synthesis and 47% on generics. Exports to the US and Europe constitute 72% of total revenue.
The company has cash on books of Rs 3659 crores, as on December 31, 2025.
Stock Trading
Maximise Returns by Investing in the Right Companies
By — The Economic Times, Get Certified By India's Top Business News Brand
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
By — Saketh R, Founder- QuickAlpha, Full Time Options Trader
Stock Trading
Technical Analysis for Everyone — Technical Analysis Course
By — Abhijit Paul, Technical Research Head, Fund Manager- ICICI Securities
Stock Trading
Stock Markets Made Easy
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Renko Chart Patterns Made Easy
By — Kaushik Akiwatkar, Derivative Trader and Investor
Stock Trading
Market 101: An Insight into Trendlines and Momentum
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
Markets 102: Mastering Sentiment Indicators for Swing and Positional Trading
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
Dow Theory Made Easy
By — Vishal Mehta, Independent Systematic Trader
Stock Trading
Market 103:
